DelPiccolo Nico, Onkendi Edwin, Nguyen Justin, Patel Shreya, Asbun Horacio J, Burns Justin, Croome Kristopher, Obi Johnathan R, Stauffer John A
Department of Surgery, Mayo Clinic, Jacksonville, Florida, USA.
J Laparoendosc Adv Surg Tech A. 2020 Jul;30(7):790-796. doi: 10.1089/lap.2019.0615. Epub 2020 Apr 23.
Minimally invasive major hepatic resection (MIMHR) is increasingly being performed in tertiary centers using either hand-assisted laparoscopic surgery (HALS) or totally laparoscopic surgery (TLS). The outcomes data of MIMHR are scarce, especially in comparison to open major hepatic resection (OMHR). Our aim was to compare 90-day outcomes in major hepatic resections when minimally invasive approaches are attempted. At our institution, minimally invasive liver resection was formally introduced in January 2007, initially using the HALS approach. Since then, the use of TLS approach has increased. We collected data on all patients who underwent major liver resection between January 2007 and December 2017 at our institution. In an intention to treat fashion, we then compared MIMHR to OMHR. From January 2007 to December 2017, 669 patients underwent liver resection. Of these, 203 patients (30%) underwent major hepatic resection and MIMHR and OMHR were performed in 68 (33%) and 135 (67%) patients, respectively. The rate of conversion from minimally invasive to open was 30.9%. Overall, there were no significant differences in 90-day mortality (2.9% versus 1.5%; = .499) or major complications (14.7% versus 14.8%; = .985). MIMHR was associated with a shorter average postoperative hospital stay (6.2 days versus 7.9 days; = .0110) and shorter average ICU stay (0.66 days versus 0.90 days; = .0299) compared with OMHR. The minimally invasive approach to major liver resection is a safe and reasonable alternative to an open approach when performed by a surgeon experienced with the relevant surgical techniques. MIMHR may be associated with similar outcomes and a shorter postoperative hospital stay with no increase in 90-day postoperative complications to OMHR.
微创肝大部切除术(MIMHR)在三级医疗中心越来越多地通过手辅助腹腔镜手术(HALS)或全腹腔镜手术(TLS)来实施。MIMHR的疗效数据稀缺,尤其是与开放性肝大部切除术(OMHR)相比。我们的目的是比较尝试采用微创方法进行肝大部切除术后90天的疗效。在我们机构,2007年1月正式引入微创肝切除术,最初采用HALS方法。从那时起,TLS方法的使用有所增加。我们收集了2007年1月至2017年12月在我们机构接受肝大部切除术的所有患者的数据。然后,我们按照意向性治疗原则,将MIMHR与OMHR进行比较。2007年1月至2017年12月,669例患者接受了肝切除术。其中,203例患者(30%)接受了肝大部切除术,MIMHR和OMHR分别在68例(33%)和135例(67%)患者中实施。微创转为开放手术的比例为30.9%。总体而言,90天死亡率(2.9%对1.5%;P = 0.499)或主要并发症(14.7%对14.8%;P = 0.985)无显著差异。与OMHR相比,MIMHR术后平均住院时间更短(6.2天对7.9天;P = 0.0110),平均重症监护病房(ICU)停留时间更短(0.66天对0.90天;P = 0.0299)。当由具有相关手术技术经验的外科医生进行时,微创肝大部切除术是开放性手术的一种安全且合理的替代方法。MIMHR可能具有相似的疗效,术后住院时间更短,且术后90天并发症不增加。